Patents by Inventor Elias Said

Elias Said has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
    Patent number: 8173767
    Abstract: The present invention relates to peptides, referred to as CBD-1, CBD-2, CBM-1/TH-1, CBM-1/TH-2, CBM-2/TH-1, CBM-2/TH-2 and C-20 peptides, which are antigenic and elicit a protective immune response against HIV infection. Compositions, pharmaceutical compositions and vaccines comprising these antigenic peptides are also encompassed by the present invention, as well as neutralizing antibodies which inhibit infection of primary CD4+ T lymphocytes by various HIV isolates. Methods for diagnosis of HIV are also disclosed.
    Type: Grant
    Filed: March 11, 2008
    Date of Patent: May 8, 2012
    Assignees: Institut Pasteur, Centre National de la Recherche Scientifique
    Inventors: Ara Hovanessian, Jean-Paul Briand, Sylviane Muller, Bernard Krust, Josette Svab, Elias Said
  • Novel synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
    Publication number: 20100247618
    Abstract: The present invention relates to peptides, referred to as CBD-1, CBD-2, CBM-1/TH-1, CBM-1/TH-2, CBM-2/TH-1, CBM-2/TH-2 and C-20 peptides, which are antigenic and elicit protective immune response against HIV infection. Compositions, pharmaceutical compositions and vaccines comprising these antigenic peptides are also encompassed by the present invention, as well as neutralizing antibodies which inhibit infection of primary CD4+ T lymphocytes by various HIV isolates. Methods for diagnosis of HIV are also disclosed.
    Type: Application
    Filed: March 11, 2008
    Publication date: September 30, 2010
    Inventors: Ara Hovanessian, Jean Paul Briand, Sylviane Muller, Bernard Krust, Josette Svab, Elias Said
  • Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
    Patent number: 7364744
    Abstract: The present invention relates to peptides, referred to as CBD-1, CBD-2, CBM-1/TH-1, CBM-1/TH-2, CBM-2/TH-1, CBM-2/TH-2 and C-20 peptides, which are antigenic and elicit a protective immune response against HIV infection. Compositions, pharmaceutical compositions and vaccines comprising these antigenic peptides are also encompassed by the present invention, as well as neutralizing antibodies which inhibit infection of primary CD4+ T lymphocytes by various HIV isolates. Methods for diagnosis of HIV are also disclosed.
    Type: Grant
    Filed: April 9, 2004
    Date of Patent: April 29, 2008
    Assignees: Institut Pasteur, Centre National de la Recherche Scientifique
    Inventors: Ara Hovanessian, Jean-Paul Briand, Sylviane Muller, Bernard Krust, Josette Svab, Elias Said
  • E-field mapping
    Publication number: 20060087324
    Abstract: The present invention provides a sensor device for measuring an electric field in a charge carrying medium. To this end, the sensor device defines a sensor space that is arranged to receive the charge carrying medium, and that comprises terminals for applying an electric field across the sensor space. Furthermore, sensor elements are arranged spatially separated in the sensor space. The sensor elements are operable to perform electrochemistry in response to the electric field and to change optical appearance upon said electrochemistry. Thereby electric field present in said sensor space is detectable from an optical appearance of said sensor elements.
    Type: Application
    Filed: October 1, 2004
    Publication date: April 27, 2006
    Applicant: ACREO AB
    Inventors: Magnus Berggren, Nathaniel Robinson, Elias Said, David Nilsson, Per-Olof Svensson, Jessica Hall
  • Novel synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
    Publication number: 20050124540
    Abstract: The present invention relates to peptides, referred to as CBD-1, CBD-2, CBM-1/TH-1, CBM-1/TH-2, CBM-2/TH-1, CBM-2/TH-2 and C-20 peptides, which are antigenic and elicit a protective immune response against HIV infection. Compositions, pharmaceutical compositions and vaccines comprising these antigenic peptides are also encompassed by the present invention, as well as neutralizing antibodies which inhibit infection of primary CD4+ T lymphocytes by various HIV isolates. Methods for diagnosis of HIV are also disclosed.
    Type: Application
    Filed: April 9, 2004
    Publication date: June 9, 2005
    Inventors: Ara Hovanessian, Jean-Paul Briand, Sylviane Muller, Bernard Krust, Josette Svab, Elias Said